Text this: Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A_2A Adenosine and AChE Receptors, Brain GLP-1 Response and Its Brain/Plasma Concentration Ratio after 28 Days Multiple Doses in Rats Using LC-MS/MS